{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:57Z","timestamp":1786979937342,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T00:00:00Z","timestamp":1326499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00277-011-1395-9","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T06:01:53Z","timestamp":1326693713000},"page":"931-939","source":"Crossref","is-referenced-by-count":76,"title":["Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study"],"prefix":"10.1007","volume":"91","author":[{"name":"Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Rigacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendetta","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dodero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Iacopino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Falda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo Fabrizio","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosi","family":"Oneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,14]]},"reference":[{"issue":"7","key":"1395_CR1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood.V77.7.1587.1587","volume":"77","author":"T Philip","year":"1991","unstructured":"Philip T, Chauvin F, Armitage J, Bron D, Hagenbeek A, Biron P, Spitzer G, Velasquez W, Weisenburger DD, Fernandez-Ranada J, Somers R, Rizzoli V, Harousseau JL, Sotto JJ, Cahn JY, Gullhot F, Biggs J, Sonneveld P, Misset JL, Manna A, Jagannath S, Guglielmi C, Chevreau C, Delmer A, Santini G, Coiffier B (1991) Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 77(7):1587\u20131592","journal-title":"Blood"},{"issue":"9","key":"1395_CR2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2009.007005","volume":"94","author":"U Vitolo","year":"2009","unstructured":"Vitolo U, Chiappella A, Angelucci E, Rossi G, Liberati AM, Cabras MG, Botto B, Ciccone G, Gaidano G, Falchi L, Freilone R, Novero D, Orsucci L, Pavone V, Pogliani E, Rota-Scalabrini D, Salvi F, Tonso A, Tucci A, Levis A (2009) Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Hematologica 94(9):1250\u20131258","journal-title":"Hematologica"},{"issue":"12","key":"1395_CR3","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/annonc\/mdp237","volume":"20","author":"C Haioun","year":"2009","unstructured":"Haioun C, Mounier N, Emile JF, Ranta D, Coiffier B, Tilly H, Recher C, Ferm\u00e9 C, Gabarre J, Herbrecht R, Morchhauser F, Gisselbrecht C (2009) Rituximab versus observation after high dose consolidative first-line chemotherapy with autologous stem cell transplantation in patients with poor risk diffuse large-B cell lymphoma. Ann Oncol 20(12):1985\u20131992","journal-title":"Ann Oncol"},{"issue":"8","key":"1395_CR4","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood.V80.8.2142.2142","volume":"80","author":"JM Vose","year":"1992","unstructured":"Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J, Prappier B, Schmit-Pokorny K, Weisenburger DD, Armitage JO (1992) Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 80(8):2142\u20132148, 15","journal-title":"Blood"},{"key":"1395_CR5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1200\/JCO.1997.15.4.1595","volume":"15","author":"E Vanderbenghe","year":"1997","unstructured":"Vanderbenghe E, Pearce R, Taghipour G, Fouillard L, Goldstone AH (1997) Role of a second transplant in the management of poor prognosis lymphomas: a report from the European Blood and Marrow Registry. J Clin Oncol 15:1595\u20131600","journal-title":"J Clin Oncol"},{"key":"1395_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1700614","volume":"19","author":"M Lima de","year":"1997","unstructured":"de Lima M, van Besien KV, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE (1997) Bone marrow transplantation after failure of autologous transplant for non-Hodgkin\u2019s lymphoma. Bone marrow transplant 19:121\u2013127","journal-title":"Bone marrow transplant"},{"key":"1395_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555\u2013562","journal-title":"Blood"},{"key":"1395_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN (1993) Gene-marking to trace origin or relapse after autologous bone marrow transplantation. Lancet 341:85\u201386","journal-title":"Lancet"},{"key":"1395_CR9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R, Philip T, Petersen F, Appelbaum F, De Vol E, Ernst P (1992) Autologous versus allogeneic bone marrow transplantation for non Hodgkin\u2019s lymphoma: a case controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 10:1690\u20131695","journal-title":"J Clin Oncol"},{"key":"1395_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"77","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambinder RF, Piantadosi S, Santos GW (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649\u2013653","journal-title":"Blood"},{"key":"1395_CR11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F, Cummings G, Sensenbrenner LL (1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non Hodgkin\u2019s lymphoma. Blood 84:1050\u20131055","journal-title":"Blood"},{"key":"1395_CR12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1702625","volume":"26","author":"AD Schimmer","year":"2000","unstructured":"Schimmer AD, Jamal S, Messner H, Keating A, Maharchand J, Huebsch L, Walker I, Benger A, Gluck S, Smith A (2000) Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin\u2019s lymphoma (NHL): results of a provincial strategy. Ontario BMT Network. Bone Marrow Transplant 26:859\u2013864","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1702191","volume":"25","author":"CL Toze","year":"2000","unstructured":"Toze CL, Shepherd JD, Connors JM, Voss NJ, Gascoyne RD, Hogge DE, Klingemann HG, Nantel SH, Nevill TJ, Philips GL, Reece DE, Sutherland HJ, Barnett MJ (2000) Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia. Bone Marrow Transplant 25:605\u2013612","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1083-8791(00)70009-7","volume":"6","author":"JP Radich","year":"2000","unstructured":"Radich JP, Gooley T, Sanders JE, Anasetti C, Chauncey T, Appelbaum FR (2000) Second allogeneic transplantation after failure of first autologous transplantation. Biol Blood Marrow Transplant 6:272\u2013279","journal-title":"Biol Blood Marrow Transplant"},{"key":"1395_CR15","first-page":"1832","volume":"92","author":"K Besien van","year":"1998","unstructured":"van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL Jr, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM (1998) Allogeneic bone marrow transplantation for low grade lymphoma. Blood 92:1832\u20131836","journal-title":"Blood"},{"key":"1395_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2004.05251.x","volume":"128","author":"KS Peggs","year":"2004","unstructured":"Peggs KS, Mackinnon S, David L (2004) The role of allogeneic transplantation in non-Hodgkin\u2019s lymphoma. British Journal of Hematology 128:153\u2013168","journal-title":"British Journal of Hematology"},{"key":"1395_CR17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 91:756\u2013763","journal-title":"Blood"},{"key":"1395_CR18","first-page":"1021","volume":"25","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume KG, Storb RF (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 25:1021\u20131028","journal-title":"Blood"},{"key":"1395_CR19","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","volume":"98","author":"IF Khouri","year":"2001","unstructured":"Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, Korbling M, Younes A, Ippoliti C, Gajewski JL, McLaughlin P, Anderlini P, Donato ML, Cabanillas FF, Champlin RE (2001) Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease and treatment-related mortality. Blood 98:3595\u20133599","journal-title":"Blood"},{"issue":"29","key":"1395_CR20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1200\/JCO.2010.30.2596","volume":"10","author":"RJ Kampen van","year":"2011","unstructured":"van Kampen RJ, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant JP, Buzyn A, Boogaerts MA, Luan JJ, Maury S, Milpied NJ, Jouet JP, Ossenkoppele GJ, Sureda A (2011) Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin\u2019s lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation registry. J Clin Oncol 10(29):1342\u20131348","journal-title":"J Clin Oncol"},{"key":"1395_CR21","unstructured":"SPSS Inc.SPSS for Windows, version 12.0 Chicago: SPSS Inc. 1998"},{"key":"1395_CR22","unstructured":"NCSS97 Number Cruncher Statistical System, Kaysville, UT, USA"},{"key":"1395_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bmt.1703888","volume":"31","author":"O Paltiel","year":"2003","unstructured":"Paltiel O, Rubinstein C, Or R, Nagler A, Gordon L, Deutsch L, Polliack A, Naparstek E (2003) Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma. Bone Marrow Transplant 31:565\u2013569","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR24","first-page":"119","volume":"4","author":"HC Schouten","year":"1989","unstructured":"Schouten HC, Armitage JO, Klassen LW, Vaughan WP, Bierman PJ, Weisenburger D, Kessinger A (1989) Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. Bone Marrow Transplant 4:119\u2013121","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","volume":"20","author":"T Tsai","year":"1997","unstructured":"Tsai T, Goodman S, Saez R, Schiller G, Adkins D, Callander N, Wolff S, Freytes CO (1997) Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation. Bone Marrow Transplant 20:859\u2013863","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1395_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/blre.1999.0125","volume":"14","author":"P Bierman","year":"2000","unstructured":"Bierman P (2000) Allogeneic bone marrow transplantation for lymphoma. Blood Rev 14(1):1\u201313","journal-title":"Blood Rev."},{"key":"1395_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/bbmt.2002.v8.pm12014811","volume":"8","author":"AJ Shah","year":"2002","unstructured":"Shah AJ, Kapoor N, Weinberg KI, Crooks GM, Kohn DB, Lenarsky C, Kaufman F, Epport K, Wilson K, Parkman R (2002) Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up. Biol Blood Marrow Transplant 8:221\u2013228","journal-title":"Biol Blood Marrow Transplant"},{"key":"1395_CR28","first-page":"39","volume":"17","author":"KY Chiang","year":"1996","unstructured":"Chiang KY, Weisdorf DJ, Davies SM, Enright H, Kersey JH, McGlave PB, Miller W, Ramsay NK, Steinbuch M, Wagner JE, Blazar BR (1996) Outcome of second bone marrow transplantation following uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 17:39\u201342","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR29","unstructured":"Horowitz MM, Bortin MM (1990) Current status of allogeneic bone marrow transplantation. Clin Transpl. 41-52"},{"key":"1395_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","volume":"100","author":"KW Besien van","year":"1996","unstructured":"van Besien KW, Mehra RC, Giralt SA, Kantarjian HM, Pugh WC, Khouri IF, Moon Y, Williams P, Andersson BS, Przepiorka D, McCarthy PL, Gajewski JL, Deisseroth AB, Cabanillas FF, Chakmplin RR (1996) Allogeneic bone marrow transplantation for poor prognosis lymphoma: response, toxicity and survival depend on disease histology. Am J Med 100:299\u2013307","journal-title":"Am J Med"},{"key":"1395_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.bmt.1702101","volume":"25","author":"I Blau","year":"2000","unstructured":"Blau I, Basara N, Bischoff M, Gunzelmann S, Romer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA (2000) Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Bone Marrow Transplant 25:41\u201345","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR32","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"85","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, Van Besien K, Rondon G, Anderlini P, O\u2019Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andresson B, Beran M, Przepiorka D, Koller C, Kornblau S, Korbling M, Keating M, Kantarjian H, Champlin R (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 85:4531\u20134538","journal-title":"Blood"},{"key":"1395_CR33","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"PD Kottanidis","year":"2000","unstructured":"Kottanidis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S, Peggs K, Verfuerth S, Pettengell R, Marsch JC, Schey S, Mahendra P, Morgan GJ, Hale G, Waldmann H, de Elvira MC, Williams CD, Devereux S, Linch DC, Goldstone AH, Mackinnon S (2000) In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood 96:2419\u20132425","journal-title":"Blood"},{"key":"1395_CR34","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","volume":"100","author":"SP Robinson","year":"2002","unstructured":"Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russel N, de Elvira CR, Taghipour G, Schmitz N (2002) Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the lymphoma working party of the European group for blood and bone marrow transplantation. Blood 100:4310\u20134316","journal-title":"Blood"},{"key":"1395_CR35","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1200\/JCO.2004.09.092","volume":"22","author":"MP Escalon","year":"2004","unstructured":"Escalon MP, Champlin RE, Saliba RM, Acholonu SA, Hosing C, Fayad L, Giralt S, Ueno NT, Maadani F, Pro B, Donato M, McLaughlin P, Khouri IF (2004) Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin\u2019s lymphoma whose disease has failed a prior autologous transplantation. J Clin Oncol 22:2419\u20132423","journal-title":"J Clin Oncol"},{"key":"1395_CR36","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/sj.leu.2404822","volume":"21","author":"P Corradini","year":"2007","unstructured":"Corradini P, Dodero A, Farina L, Fanin R, Patriarca F, Miceli R, Matteucci P, Bregni M, Scime R, Narni F, Pogliani E, Locasciulli A, Dilani R, Carniti C, Bacigalupo A, Rambaldi A, Bonifazi F, Olivieri A, Gianni AM, Tarella C (2007) Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pretransplant disease status and histotype heavily influence outcome. Leukemia 21:2361\u20132323","journal-title":"Leukemia"},{"key":"1395_CR37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2003-05-1406","volume":"103","author":"RD Faulkner","year":"2004","unstructured":"Faulkner RD, Craddock C, Byrne JL, Mahendra P, Haynes AP, Prentice HG, Potter M, Pagliuca A, Ho A, Devereux S, McQuaker G, Mufti G, Yin JL, Russel NK (2004) BEAM-Campath reduced intensity allogeneic stem cell transplantation for lymphoproliferative disease: GVHD, toxicity and survival in 65 patients. Blood 103:428\u2013434","journal-title":"Blood"},{"key":"1395_CR38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbmt.2005.04.005","volume":"11","author":"RM Dean","year":"2005","unstructured":"Dean RM, Fowler DH, Wilson WH, Odom J, Steinberg SM, Chow C, Kasten-Sportes C, Gress RE, Bishop MR (2005) Efficacy of reduced intensity allogeneic stem cell transplantation in chemotherapy refractory non-Hodgkin lymphoma. Biol Blood Marrow Transplant 11:593\u2013599","journal-title":"Biol Blood Marrow Transplant"},{"key":"1395_CR39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","volume":"25","author":"A Nagler","year":"2000","unstructured":"Nagler A, Slavin S, Varadi G, Naparstek E, Samuel S, Or R (2000) Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplant 25:1021\u20131028","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR40","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F, Carcciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C (2004) Graft versus lymphoma effect in relapsed peripheral T-cell non Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed allogeneic transplantation of hematopoietic cells. J Clin Oncol 22:2172\u20132176","journal-title":"J Clin Oncol"},{"key":"1395_CR41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1705027","volume":"36","author":"E Kusumi","year":"2005","unstructured":"Kusumi E, Karni M, Kanda Y, Murashige N, Kishi Y, Suzuki R, Takeuchi K, Tanimoto TE, Mori T, Muta K, Tamaki T, Tanaka Y, Ogawa H, Yamane T, Taniguchi S, Takaue Y (2005) Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan. Bone Marrow Transplant 36:205\u2013213","journal-title":"Bone Marrow Transplant"},{"key":"1395_CR42","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2004-03-1105","volume":"104","author":"E Morris","year":"2004","unstructured":"Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, Cook G, Smith GM, Parker A, Schey S, Chopra R, Hatton C, Tighe J, Hunter A, Peggs K, Linch D, Goldstone A, Mackinnon S (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 104:3865\u20133871","journal-title":"Blood"},{"key":"1395_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V99.1.75","volume":"99","author":"P Corradini","year":"2002","unstructured":"Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, Ladetto M, Falda M, Lucesole M, Dodero A, Ciceri F, Benedetti F, Rambaldi A, Sajeva MR, Tresoldi M, Pileri A, Bordignon C, Bregni M (2002) Reduced-intensity conditioning followed by all grafting of hematopoietic cells can produce clinical and molecular remission in patients with poor-risk hematologic malignancies. Blood 99:75\u201382","journal-title":"Blood"},{"key":"1395_CR44","first-page":"3744","volume":"32","author":"PJ Bierman","year":"2003","unstructured":"Bierman PJ, Sweetenham JW, Jr L, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, vose JM, Horowitz M, Goldstone A (2003) Syngenic hematopoietic stem cell transplantation for non-Hodgkin\u2019s lymphoma: a comparison with allogeneic and autologous transplantation. The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation J Clin Oncol 32:3744\u20133753","journal-title":"The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J. Clin. Oncol."},{"key":"1395_CR45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3324\/haematol.13441","volume":"94","author":"SP Robinson","year":"2009","unstructured":"Robinson SP, Sureda A, Canals C, Russel N, Caballero D, Bacigalupo A, Iriondo A, Cook G, Pettitt A, Socie G, Bonifazi F, Bosi A, Michallet M, Liakopoulou E, Maertens J, Passweg J, Clarke F, Martino R, Schmitz N (2009) Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin\u2019s lymphoma: identification of prognostic factors predicting oucome. Hematologica 94:230\u2013238","journal-title":"Hematologica"},{"key":"1395_CR46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2141.2008.07365.x","volume":"143","author":"AR Rezvani","year":"2008","unstructured":"Rezvani AR, Norasetthada L, Gooley T, Sorror M, Bouvier ME, Sahebi F, Agura E, Chauncey T, Maziarz RT, Maris M, Shizuru J, Bruno B, Bredeson C, Lange T, Yeager A, Sandmaier BM, Storb RF, Maloney DG (2008) Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicenter experience. Br J Hematol 143:395\u2013403","journal-title":"Br. J. Hematol."},{"issue":"1","key":"1395_CR47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbmt.2009.09.002","volume":"16","author":"A Sirvent","year":"2010","unstructured":"Sirvent A, Dhedin N, Michallet M, Mounier N, Faucher C, Yakoub-agha I, Mohty M, Robin M, Tabrizi R, Clement L, Bilger K, Larosa F, Contentin N, Huyn A, Francos S, Bulabois CE, Ceballos P, Bourrhis JH, Buzyn A, Cornilllon J, Guillerm G, de Revel T, Bay JO, Guilhot F, Milpied N (2010) Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Soci\u00e9t\u00e9 Francaise de Greffe de Moelle et de Th\u00e9rapie Cellulaire. Biol Blood Marrow Transplant 16(1):78\u201385","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1395-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1395-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T17:39:54Z","timestamp":1593538794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1395-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,14]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1395-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,14]]}}}